People: StemCells Inc (STEM.O)

STEM.O on Consolidated Issue listed on NASDAQ Capital Market

0.99USD
27 Mar 2015
Change (% chg)

$0.01 (+1.33%)
Prev Close
$0.98
Open
$0.98
Day's High
$0.99
Day's Low
$0.98
Volume
303,495
Avg. Vol
604,041
52-wk High
$2.43
52-wk Low
$0.84

Search Stocks

McGlynn, Martin 

Mr. Martin M. McGlynn is Chief Executive Officer, Director of the Company. He served as President, Chief Executive Officer, Director of StemCells, Inc. He has held management positions of increasing responsibility in several countries for more than 30 years. Prior to joining our company, Mr. McGlynn was President and Chief Executive Officer of Pharmadigm, Inc., a privately held company in the fields of inflammation and genetic immunization. Prior to this, he was President and General Manager of Abbott Canada Ltd. and President of Anaquest, Inc., a company focused on anesthesia and acute care pharmaceuticals.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
835,836 -- 43,258 2,118,090

Options Compensation

  Quantity Market Value
Exercisable 844,791 1,121,590.00
Unexercisable 330,209 683,635.00
Exercised 146,000 376,680.00
Name Fiscal Year Total

John Schwartz

--

Ian Massey

--

Martin McGlynn

2,118,090

Gregory Schiffman

--

Ann Tsukamoto

999,533

Kenneth Stratton

544,819
As Of  30 Dec 2013
Search Stocks